Decreased resistance of TNF receptor p55- and p75-deficient mice to chronic toxoplasmosis despite normal activation of inducible nitric oxide synthase in vivo.
The importance of TNF-alpha in host defense to the intracellular parasite, Toxoplasma gondii, was investigated in mice lacking both the p55 and p75 receptors for this cytokine. Upon i.p. infection with the avirulent ME49 strain, knockout mice were capable of limiting acute i.p. infection, but succumbed within 3 to 4 wk to a fulminant necrotizing encephalitis. Receptor-deficient mice harbored higher cyst burdens and exhibited uncontrolled tachyzoite replication in the brain. The lack of TNF receptors did not adversely affect the development of a type 1 IFN-gamma response. In vitro studies with peritoneal macrophages stimulated with IFN-gamma and tachyzoites indicated that under limiting concentrations of IFN-gamma, nitric oxide-mediated toxoplasmastatic activity is TNF-alpha dependent. However, this requirement is overcome by increasing the dose of IFN-gamma. Furthermore, both ex vivo and in vivo studies demonstrated that inducible nitric oxide synthase induction in the peritoneal cavity and brain is unimpaired in receptor-deficient mice. Thus, TNF-dependent immune control of T. gondii expansion in the brain involves an effector function distinct from inducible nitric oxide synthase activation.
Yap
G S
GS
Immunobiology Section, Laboratory of Parasitic Diseases, National Institutes of Allergy and Infectious Diseases, Bethesda, MD 20892, USA.
Scharton-Kersten
T
T
Charest
H
H
Sher
A
A
D000818:Animals; D015703:Antigens, CD / Q000032:analysis* / Q000235:genetics*; D002908:Chronic Disease; D016207:Cytokines / Q000096:biosynthesis; D004789:Enzyme Activation / Q000235:genetics / Q000276:immunology; D004790:Enzyme Induction / Q000235:genetics / Q000276:immunology; D007113:Immunity, Innate; D017737:Macrophages, Peritoneal / Q000201:enzymology / Q000469:parasitology; D051379:Mice; D008810:Mice, Inbred C57BL; D018345:Mice, Knockout; D019001:Nitric Oxide Synthase / Q000096:biosynthesis*; D052247:Nitric Oxide Synthase Type II; D018124:Receptors, Tumor Necrosis Factor / Q000032:analysis* / Q000172:deficiency* / Q000235:genetics*; D047888:Receptors, Tumor Necrosis Factor, Type I; D047889:Receptors, Tumor Necrosis Factor, Type II; D018417:Th1 Cells / Q000378:metabolism; D014122:Toxoplasma / Q000276:immunology; D014124:Toxoplasmosis, Animal / Q000201:enzymology / Q000235:genetics / Q000276:immunology*
D015703:Antigens, CD; D016207:Cytokines; D018124:Receptors, Tumor Necrosis Factor; D047888:Receptors, Tumor Necrosis Factor, Type I; D047889:Receptors, Tumor Necrosis Factor, Type II; D019001:Nitric Oxide Synthase; D052247:Nitric Oxide Synthase Type II; C496317:Nos2 protein, mouse